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Abstract 
Sepsis costs over 20 billion dollars annually to treat making it the most expensive diagnosis for 
hospitals (Afrefian, et al., 2017) and carries with it an average mortality rate of 45% (SCCM, 
2016).  The eICU/ICU collaborative project was developed to improve sepsis mortality at Sutter 
Health’s Solano hospital affiliate from 41.2% to the system-wide goal of 18.8% over the course 
of a year by implementing two technologies. The first was the onboarding of the non-invasive 
cardiac output monitoring (NICOM) technology by Sutter Solano to fulfill the 6-hour bundle 
compliance for septic shock resuscitation. The other technology was the activation and 
enhancement of the Core Measure Manager (CMM) high-quality data surveillance technology by 
Sutter’s eICU to screen all patients at Sutter Solano Medical Center for early identification and 
treatment of sepsis and septic shock.  After twelve months of quality improvement measures 
including education, training, implementation, enhancement, tracking and treatment 
management; the dashboards revealed Sutter Solano’s sepsis/septic shock mortality rate dropped 
from 41.2% to 6.1%. Nurses and physicians need to recognize that central venous pressure 
(CVP) is no longer a recommended or accepted measure of hemodynamic stability. The latest 
evidence-based practice supports NICOM in conjunction with passive leg raise (PLR) as a 
foundational guideline for fluid resuscitation.  The Clinical Nurse Leader (CNL), as systems 
analyst and risk anticipator, must manage information as well as the care environment to 
improve quality patient outcomes in the presence of evolving knowledge and the ever-changing 
healthcare system (AACN, 2013). 
Keywords: eICU, telemedicine, interdisciplinary collaboration, quality improvement, 
hemodynamic monitoring, high-quality data surveillance, NiCOM, vasopressors, sepsis/septic 
shock, mortality, early goal-directed therapy (EGDT), fluid resuscitation 
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eICU/ICU Collaborative to Reduce Sepsis Mortality 
The diagnosis of Sepsis or Septic Shock carries with it a high mortality rate as well as 
high costs to patients and the systems which provide the care these patients need.  Klompas and 
Rhee (2016), with grant funding support from the Centers for Disease Control (CDC), performed 
a research into sepsis surveillance.  They support the early identification and treatment of sepsis 
which continues to evolve with technology and information systems.  The teams which deliver 
this care must accommodate the latest evidence-based practice (EBP) to provide the best possible 
outcomes for their patients.  The Clinical Nurse Leader (CNL), as systems analyst and risk 
anticipator, must manage information as well as the care environment to improve quality patient 
outcomes in the presence of evolving knowledge and the ever-changing healthcare system.  The 
following is an account of the collaborative clinical outcomes management of septic patients at 
Sutter Solano Medical Center. 
The electronic-intensive care unit/ intensive care unit (eICU/ICU) collaborative project 
aims to improve sepsis mortality outcomes at Sutter Solano.  The project began on June 1, 2016 
with an ICU/eICU collaborative for quality improvement.  The project ends May 1, 2017, with 
the roll-out of the April 2017 benchmark reports or when the sepsis mortality reaches 18.8%, the 
organizational target.  By working on this process, the team expects to decrease mortality rates 
for septic patients from 41.2% to 18.8%.  It is important to do this work now to save patient’s 
lives, to improve their long-term outcomes and to reduce cost burdens of hospitalization and self-
care management. 
The project is an evidence-based activity that plans to improve performance, delivery and 
quality of care.  It involves implementation of established and tested quality standards for 
hemodynamic monitoring as well as enhancing and implementing existing high quality data 
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surveillance technologies.  The project provides performance measures to ensure compliance 
with existing quality standards, care practices and interventions.  Further this project received no 
funding from federal agencies or research organizations.  All Sutter Health names and 
information were used with permission from Sutter Health’s quality documentation and quality 
risk managers. 
                                 Clinical Leadership Theme 
The CNL theme involved in this project is consistent with organizational and systems 
leadership.  This project required the CNL to assume a leadership role within the 
interprofessional team using effective communication to successfully implement a collaborative 
patient safety and quality improvement initiative (AACN, 2013).  The first aspect of the 
collaborative requires that Sutter Solano Medical Center on-board a non-invasive cardiac output 
monitoring (NICOM) device to determine fluid responsiveness and better guide therapies in their 
septic patients.  Because the eICU is integral in the critical care management of these patients, 
the CNL must laterally integrate and coordinate the education of the eICU staff to the NICOM 
equipment.  Further, as a liaison between members of a health care team, the CNL will ensure 
lateral partnering with the bedside quality improvement team consisting of nurses, physicians, 
pharmacists and laboratory personnel to manage necessary early treatment in this vulnerable 
patient population. 
The CNL leadership theme (AACN, 2007) also pertains to being an information manager 
utilizing information systems and technology at the point of care to improve patient outcomes.  
The CNL will partner with eICU management, pharmacy and electronic health record (EHR) 
personnel to evaluate the impact of the new high-quality data surveillance core measure manager 
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technology (CMM) on patient outcomes.  Together they will manage the information to 
continually improve and enhance this technology to its effective and meaningful use. 
Statement of the Problem 
The problem occurred as the mortality outcomes for septic patients at Sutter Solano rose 
to 41.2%, well over the national average of approximately 28.8% and the system-wide threshold 
of 18.8%.  The query is whether the incorporation of hemodynamic monitoring for fluid 
responsiveness and the use of high-quality data surveillance can improve the mortality rate to the 
system-wide threshold of 18.8%.  Careful consideration for the impact of the eICU/ICU 
collaborative effort is required to effectively evaluate this project.  The hands-on care is provided 
by Sutter Solano’s critical care and emergency room nurses and hospitalists while the remotely 
located eICU expert critical care nurses and intensivists manage these critically ill patients 
during off-hours.  Further, the high-quality data surveillance CMM technology which screens all 
of Sutter Solano’s patients for sepsis, is managed by the eICU nursing team.  
Rationale  
According to the Society of Critical Care Medicine (2016), 20% of the annual 5.7 million 
patients admitted to hospitals go to an intensive care unit.  Additionally, 58% of emergency room 
admissions result in an ICU admission.  Sepsis is the second leading cause of death in non-
coronary ICUs with a mortality rate of up to 45%.  Afrefian, et al., (2017) tell us that hospitals 
spend over 20 billion dollars annually to treat sepsis making it the most expensive diagnosis to 
treat.  What stakeholders need to know is that $1 billion per quality life year gained can be saved 
through quality critical care management of severe sepsis, acute respiratory failure and general 
critical care interventions (SCCM, 2016).  Critical Care management, which is provided by the 
eICU on average16 hours/day, consists of early recognition; timely, appropriate and consistent 
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treatment; and the provision of expert guidance for emergent interventions.  It must also be 
consistent with the latest EBP.  This project explores the latest EBP and the variance from the 
treatment that has guided septic shock resuscitation for the last twelve years as a potential for 
improvement in quality outcomes for septic patients. 
                                        Project Overview 
A project analysis revealed a pattern of increasing mortality for septic patients at Sutter 
Solano Medical Center.  The purpose of the eICU is to improve patient quality outcomes through 
increased collaboration and through provision of board certified intensivist and expert critical 
care nurses and staff.   The process analysis during the rolling months of February-April 2016, 
revealed Sutter Solano had a severe sepsis/septic shock mortality rate of 41.2%, well above the 
national average of 14.7 to 29.9% (Gaieski, Edwards, Kallan & Carr, 2013).  Solano’s data 
revealed greater than 85% compliance with 3-hour bundles: measuring a lactate level; drawing 
blood culture; giving the antibiotic within an hour of a sepsis alert/diagnosis; and adequate fluid 
resuscitation.  They also provided vasopressors appropriately.  Their compliance decreased to 
77.3% for remeasuring lactate levels greater 2.0.  Additionally, they had virtually no means of 
hemodynamic monitoring and only performed the 6-hour bundle element of a focused physical 
exam 42.9% of the time. 
The discovered need was for improved capture, follow-up and management of this 
vulnerable patient population.  To accomplish improved sepsis mortality outcomes from 41.2% 
to the organizational threshold of 18.8% by May 1, 2017, the eICU/ICU collaborative initiative 
was activated.  Quality improvement teams, unit champions and leadership from both Solano’s 
ICU and the eICU began analyzing and communicating regarding avenues for quality 
improvement measures in collaborative effort to improve these outcomes.  
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Potential problems anticipated in this project included access to equipment. Mitigating 
the impact required to expedite NICOM equipment purchases was achieved by the affiliate early 
in the initiative timeline.  High-quality data surveillance was required to screen all inpatients.  
This required working with the EHR team and the pharmacy administration to incorporate smart 
alerts that would screen for signs and symptoms of sepsis.  The progression of this process 
required frequent reconfiguring of the smart alert.  Its evolution is ongoing and feedback 
dependent.  The CMM program is a sensitive marker that grows more specific with each 
restructured iteration (see “RCA Fishbone Diagram” Appendix A). 
Cost Analysis 
There is a reasonable business case for the eICU/ICU collaborative project to reduce 
sepsis mortality at Sutter Solano Medical Center from 41.2% to the system-wide benchmark of 
18.8%.  The costs for this project include 400 student practicum hours at hypothetical $65.00/h 
for a total of $26,000.00, and the purchase and adoption of two new technologies.  Three 
NICOM machines, at $10,000.00 each, totaled $30,000.00.  Bedside staff training costs are to be 
determined (TBD) but estimated at less than $10,000.00.  The eICU training 
sessions/presentations costs for 15 staff at $65.00/hr totaled $975.00.  Other pharmacy and 
leadership change agents collaborated to enhance and implement the CMM program alert 
technology during time already spent productively.  Total costs equaled @ $66,975.00. 
Savings are reflected in sepsis mortality rates dropping from 41.2% in April 2016, to 
6.1% in March 2017, a 68% decrease.  Benefits to the Sutter Health System can be calculated in 
lives saved through the eICU/ICU collaborative efforts from June 2016, through April 2017.  In 
2017, ten lives were saved that were not expected to survive.  The Society of Critical Care 
Medicine (2016) states critical care management of sepsis, including acute respiratory failure 
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saved $1 billion per quality life year gained in 2005, before today’s soaring healthcare prices.   
Additionally, the qualitative benefits provided by this project impact improved sepsis mortality 
rates at Sutter Solano and improved quality of life for those patients surviving sepsis.  The 
primary key stakeholders of this project are the patients diagnosed with sepsis and septic shock. 
As other key stakeholders, the system administrators and leadership are encouraged to decrease 
mortality rates and improve outcomes.  Further stakeholders include those persons and entities 
who provide education and presentations on new technologies as well as the healthcare 
educators.  Others still are those staff who provide care to this population which include unit 
champions from eICU, ICU, ED, laboratory, pharmacy, EHR and medical physician champions.  
Each invested their time to ensure the implementation and activation of the various cycles of 
change involved in the onboarding of the NICOM and CMM technologies.  These team members 
continue to participate in the early identification and treatment as well as the critical care 
management of these patients when they respond to sepsis alerts and apply the skills required to 
manage septic shock resuscitation.  Through the application of these quality improvement 
measures, these staff significantly improve outcomes for septic patients (see “Cost Analysis” 
Appendix B). 
Methodology 
This change project began in June 2016, and was favored with strong characteristics for 
successful innovation diffusion.  According to Massoud, et al., (2006), these characteristics are: 
relative advantage; trialability; observability; communications channels; homophilous groups; 
pace of innovation/reinvention; norms, roles, and social networks; opinion leader; compatibility; 
and infrastructure.  The change was facilitated by strengths in all these factors.  Challenges 
existed only to the extent that the group was not homophilous and that staff opinion leaders were 
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sometimes the slower adopters.  Infrastructure required adoption of the new NICOM technology 
and development and enhancement of the CMM technology.  A particularly strong innovation 
characteristic was founded in the eICU’s simultaneous pursuit of the American Association of 
Critical-care Nurses’ (AACN) Beacon Award which directed the unit’s attention to internal 
quality improvement.  However, this quality improvement project was more accurately guided 
by Kotter’s (1996) eight steps to change for transformational leadership.  These steps are: to 
establish a sense of urgency; create a powerful guiding coalition; develop a vision; communicate 
the vision; empower others to act; plan for and create short-term wins; consolidate improvements 
for more change; and institutionalize new approaches. 
A sense of urgency rose when the system-wide benchmark report statistics were shared 
during the eICU Partnership Council (PC).  Increasing sepsis mortality rates at Sutter Solano 
Medical Center inspired an eICU change agent, a Solano ICU Unit Champion RN, and an eICU 
Unit Champion, who was also the CNL student, to propose a “Sutter President’s Award 
Collaboration”.  This shared vision would drastically improve sepsis mortality outcomes by 
bridging interdepartmental efforts and resources.  The Solano bedside ICU and Emergency 
Department (ED) team adopted and implemented hemodynamic monitoring.  The eICU 
implemented high quality data surveillance to identify patients with and at risk for sepsis 
throughout Sutter Solano.  The eICU team, in conjunction with the bedside care providers, then 
managed the NICOM in-time critical care interventions during off-hours. 
The eICU team communicated the vision through multiple hemodynamic monitoring 
presentations and eICU Journal Club explorations in the latest EBP for fluid responsiveness.  
Additionally, the daily knowledgeable, successful and well-directed in-time interventions with 
Solano’s septic patients empowered the eICU and ICU staff to act on the vision with regularity.  
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The high-quality data surveillance CMM program which monitors Sutter Solano for 
septic patients also provides information which was used to modify and improve the tool. 
Regular updates on Solano’s mortality rates were reported during monthly Beacon and PC 
meetings revealing continued improvement.  Wins were reported as lives saved at Sutter Solano.  
The potential spread of the CMM high-quality data surveillance technology to other affiliates 
could be determined based on benchmark results in May 2017. 
This eICU/ICU collaborative to reduce sepsis mortality at Sutter Solano Medical Center 
is a two-armed project.  The bedside team adopted and implemented hemodynamic monitoring 
equipment on all patients with a diagnosis of septic shock.  The NICOM was used to determine 
fluid responsiveness and resuscitation strategies rather than relying on the previous standard 
central venous pressure (CVP) reading.  Simultaneously, the eICU employed at Solano an 
enhanced CMM technology for high quality data surveillance screening for sepsis on all 
emergency room and inpatients.  Both units have overcome barriers and undergone nine months 
of PDSA cycles that have included technology and equipment education and implementation, 
use of screening tools and checklists and the creation of excel databases for monitoring quality 
interventions (see “SWOT Analysis” Appendix C).  
Marx and Scheeren (2016) argue that while hemodynamic monitoring is the foundation 
for determination of fluid responsiveness, CVP measures are static and therefore should not be 
used to gather this information.  They contend that these critically ill patients need physicians to 
use hemodynamic monitoring equipment regardless of their familiarity with it as their knowledge 
will grow with experience.  Sutter Solano and eICU physicians who have exposure to the latest 
EBP and NICOM technology information have been eager and willing to incorporate the change. 
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The desired goal of the collaborative project would be reached when patients diagnosed 
with sepsis and septic shock at Sutter Solano Medical Center experience improved mortality 
rates from 41.2% last year to a goal of 18.8%.  These results exceeded expectations when the 
mortality rate at Solano in March 2017, had already decreased to 6.1% through these 
interventions.  This goal was accomplished through hemodynamic monitoring to determine 
septic shock decision tree interventions such as fluid resuscitation and use of vasopressors.  A 
CMM high quality data surveillance alert system was implemented and enhanced by the eICU to 
screen all patients at Sutter Solano for sepsis and septic shock.  The quality data report for April 
of 2017, revealed results from the clinical interventions.  A comparison of this data to last year’s 
data determined this collaborative project was effective.  Skeptics of the project expressed that 
the improved results were a product of the CMM capturing more, less intensively ill patients, 
driving decreasing mortality rates by less severity.  In fact, the prior 11 months to the 
incorporation of the CMM technology had an average monthly denominator of 13.0 patients.  
The later 11 months had an average denominator of 10.36 patients. After subtracting the single 
outlying denominator of 18 from the prior 11 months, the average monthly denominator before 
CMM activation was 10.1 patients.  This variance is insignificant to drive the data’s considerable 
change in results. 
Data Source/Literature Review 
The search statement that drove this project’s literature review follows: Will 
hemodynamic monitoring for fluid responsiveness and high quality data surveillance improve the 
mortality rate outcomes for septic patients at Sutter Solano Medical center from a prior 41.2% to 
the system-wide threshold of 18.8%?  The search statement explores the population, 
intervention, comparison, outcome and timeframe (PICOT) of a change project.  The population 
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is that of all septic patients at Solano.  The interventions consist of a two-pronged collaborative 
effort use of NICOM and CMM technologies.  The comparison is between sepsis mortality data 
from April 2016, to sepsis mortality data gathered until March 2017.  The expected outcome was 
a decrease in sepsis mortality at Sutter Solano from 41.2% to 18.8%. 
The search through CINHAL, SCOPUS and PubMed databases using Boolean phrases of 
‘sepsis’ and ‘ICU’ in different combinations, with limits of peer reviewed articles and EBP in the 
last five years revealed 27 articles, 9 of which are relevant.  The search for Boolean phrases of 
‘hemodynamic’ ‘monitoring’ and ‘sepsis’ revealed 121 articles, most were older than five years 
and many others were outdated by new criteria for defining sepsis.  Included is one article from 
2001 which defined early septic shock treatment modalities and multiple other articles that argue 
for and explain hemodynamic monitoring through impedance and bioreactance processes.  
The search through CINHAL, SCOPUS and PubMed databases listed over 2000 articles 
on high quality data surveillance.  When including “Sepsis” in the Boolean phrase, only 200 
articles appeared, six of which were pertinent to this project because of their instruction and 
evaluation of efficacy and sensitivity to screening for sepsis.  Based on these literature review, 
research explaining hemodynamic monitoring evidence and high-quality data surveillance will 
be reviewed. 
Hemodynamic Monitoring Evidence 
Rivers, et al, (2001) performed a prospective, randomized control study involving 263 
participants diagnosed with severe sepsis and septic shock.  Their article provides standard 
definitions for systemic inflammatory response syndrome, (SIRS), severe sepsis and septic shock 
that continue to guide care for this vulnerable population today.  SIRS was defined as the 
presence of infection with two or more of the following associated symptoms: temperature >/= 
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38°C or </= 36°C; heart rate >90/minute; respiratory rate > 20/minute or pCO2 < 32 mm Hg; 
and white-cell count >12.0 or < 4.0.  Severe sepsis was defined as SIRS with added end-organ 
dysfunction/failure as indicated by: systolic blood pressure <90 mm Hg; Lactate >2.0; creatinine 
> 2.0; Bilirubin > 2.0; urinary output, 0.5ml/kg/hr for >2 hrs; or mean arterial pressure (MAP) < 
70 mm Hg.  Septic Shock was defined as severe sepsis with lactate >4 or the requirement of a 
vasopressor after the initial crystalloid fluid resuscitation of 20-30 ml/kg over 30 minutes.  
Rivers, et al, (2001) used the septic shock definitions as the inclusion criteria for their 
study.  Early goal-directed therapy (EGDT) was randomly provided to 130 participants and 133 
received standard care.  EGDT provided multiple treatments like vasopressors, inotropes and 
blood products but was primarily focused on providing fluid resuscitation to obtain and maintain 
a CVP of 8-12 mm Hg within the first 6 hours of diagnosis recognition.  They concluded EGDT 
provided significantly improved outcomes for patients with severe sepsis and septic shock 
including improved mortality rates of 30.5% compared to 46.5% for those provided with 
standard care (P=0.009).  They also noted decreased costs from decreased hospital length of stay 
(LOS) from 18.4±15.0 to 14.6±14.5 days, (P=0.04) (Rivers, et al., 2001). 
The SCCM, the European Society of Intensive Care Medicine and the International 
Sepsis Forum, facilitated the Surviving Sepsis Campaign (SSC) in October 2002, an international 
initiative to increase awareness and improve patient outcomes in severe sepsis.  Dellinger, et al., 
(2004) convened to develop the first iteration of the international guidelines for management of 
severe sepsis and septic shock.  Three and six-hour bundle interventions were determined with 
recommendations based on a modified Delphi grading system; A-E, with A being the highest 
recommendation.  While they incorporated evidence available through the end of 2003, the 
recommendations were heavily guided by Rivers, et al.’s (2001) findings stated above.  
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Dellinger, et al.’s (2004) three-hour bundle required an antibiotic given within the first 
hour of diagnosis, measure of a lactate level and a 30ml/kg fluid bolus given over half an hour.  
The six-hour bundle required a remeasure of a lactate if greater than 2.0 and fluid resuscitation to 
meet a CVP of 8-12 or central venous oxygen saturation (ScVO2) > 70% and the initiation of 
vasopressors to maintain a MAP > 65mmHg. 
Because evidence-based medicine is ever-evolving, Dellinger, et al., (2008), would 
update these clinical practice guidelines in 2008 and again in 2012 (Dellinger, et l., 2012) with 
various collaborators and increasing sponsorship from international organizations.  EGDT’s 
focus on aggressive fluid resuscitation and maintaining a CVP of 8-12 was evaluated by various 
studies between 2013-2014, including the Australasian Resuscitation in Sepsis Evaluation 
(ARISE), Protocolized Care for Early Septic Shock (ProCESS) and Protocolised Management in 
Sepsis (ProMISe) studies.  Angus et al., (2015) performed a systematic review and meta-analysis 
of EGDT for septic shock including findings from the ARISE, ProCESS and ProMISe studies. 
They found EGDT compared to usual care or to less invasive alternative hemodynamic 
resuscitation protocols provided no survival benefit and even increased ICU admission.  Their 
findings did not support the systematic use of EGDT in the management of all patients with 
septic shock and they did not recommend EGDT for the Surviving Sepsis Campaign guidelines.  
This opened query into appropriate treatment for septic shock. 
In their study, Nguyen, et al. (2016) performed a comprehensive committee review of 
multiple RCTs, meta-analyses, observational and comparison-control studies including 
ProCESS, ProMISe, and ARISE as well as expert opinion pieces to determine value-based 
interventions and guidelines in treatment of severe sepsis and septic shock.  The guideline 
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committee formed five groups to explore studies of various aspects of sepsis treatment: 
hemodynamics, infection, adjunctive therapies, metabolic, and ventilation.  They applied 
methodology of Grading of Recommendations Assessment, Development, and Evaluation 
(GRADE) to determine the quality of evidence and the strength of recommendations selected.  
Their recommendations are extensive and specific, but foremost, they determined that the use of 
CVP to guide fluid resuscitation can no longer be justified.  Instead they suggest the use of 
dynamic over static measures in conjunction with passive leg raise (PLR) techniques to 
determine fluid responsiveness.  Further they recommend as a best practice standard that 
hospitals and systems adopt early sepsis identification and screening.  
Rhodes et al., (2017) performed a similar committee review to revise and update the 2012 
international guidelines.  They also incorporated the GRADE methodology to determine the new 
clinical practice guidelines which echo Nguyen et al.’s (2016) findings.  Additionally, they 
proclaim sepsis/septic shock to be a medical emergency requiring immediate treatment and 
consistent follow-up, re-evaluation and management. 
Marik and Bellomo (2015) conducted a decision analysis based on the current evidence 
and contended that recent clinical trials demonstrate that aggressive fluid resuscitation to achieve 
a CVP > 8mm/Hg does not improve outcomes in patients with sepsis and septic shock.  They 
explain that sepsis is characterized by vasoplegia and venodilation and therefore is not a volume-
depleted state.  They further argue that aggressive fluid resuscitation carries with it great risk.  
They quote studies from Brandt, et al., (2009) and Rehberg, et al., (2012) who found that 
increased positive fluid balances were directly associated with increased mortality in patients 
with sepsis and septic shock. 
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The most enlightening point they made was the deleterious effects of aggressive fluid 
resuscitation in patients with left ventricular diastolic dysfunction which commonly occurs in 
patients with hypertension, diabetes, obesity and advanced age.  Considering that these 
healthcare conditions are common in most critically ill patients, they recommend only a 500-ml 
bolus of Lactated Ringers and do not recommend normal saline (NS) at all in the treatment of 
sepsis.  Marik and Bellomo, (2015) also challenge meeting the CVP and ScVO2 measures of 
EGDT as potentially harmful stating that it is important to remember that the normal CVP is 0-2 
mm/Hg.  They also found that septic patients who had ScVO2s >90% had higher predictors of 
death.  Quoting Hotchkiss and Karl (1992) they even argue that elevated lactates may not 
necessarily be associated with tissue hypoperfusion.  
The measures that Marik and Bellomo (2015) agree are consistent with improved 
outcomes are fluid resuscitation based on fluid responsiveness and early dosing of alpha-1 
agonist, Levophed.  They believe that fluid responsiveness is most accurately measured by using 
the PLR while measuring stroke volume (SV).  The PLR virtually provides a 250-500 ml bolus.  
A patient is considered fluid responsive if their SV increases by 10-15% within the first minute 
of the PLR and they can therefore benefit from a fluid bolus.  Those patients who are fluid 
responsive, receive the bolus and still remain hypotensive will benefit from early use of 
Levophed.  
Marik, Levitov, Young and Andrews (2016), performed an electronic chart review of all 
adult patients admitted to the Sentara Norfolk General Hospital general ICU over an 18-month 
course.  Additional inclusion criteria required the use of bioreactance-coupled PLR maneuver 
and carotid blood flow data.  Bioreactance is a dynamic, or everchanging, measure of cardiac 
output which can be performed non-invasively.  The PLR is performed by lifting the legs 45 
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degrees passively from the horizontal position which transfers approximately 200-300 ml of 
blood from the lower limbs toward the heart. If the stroke volume increases at least 10% from the 
baseline, then the patient is considered fluid responsive, but if it is less than 10% they are not 
fluid responsive and additional fluids could cause them harm. 
Marik, Levitov, Young and Andrews (2016), contend that only 50% of unstable patients 
are fluid responsive.  They state overzealous fluid resuscitation is associated with increased 
mortality, ICU and hospital LOS as well as poorer survival outcomes.  Their study revealed that 
monitoring the hemodynamic response during a PLR was a better determinate for fluid 
responsiveness in septic patients.  
Jakovljevic, Trenell and MacGowan (2016), reviewed recent method comparison studies 
of the use of bioimpedance and bioreactance to estimate cardiac output during fluid challenges.  
They agree with Marik, Levitov, Young and Andrews’ (2016) findings and specify that the 
bioreactance technique is more robust because it has a higher signal-to-noise ratio. They 
conclude that a PLR maneuver coupled with the bioreactance NICOM is a simple and accurate 
method of assessing volume responsiveness in patients with septic shock as well as other critical 
illness and instability. 
In conclusion, a review of data found Sutter Solano least compliant with sepsis bundle 
guidelines of hemodynamic monitoring.  This disparity will be addressed in accordance with the 
PICOT driven literature review. Sutter Solano Medical Center will onboard NICOM technology 
in conjunction with PLR to determine fluid responsiveness to adequately treat septic shock in 
collaboration with eICU care providers. 
High-Quality Data Surveillance Evidence 
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Zhang, et al., (2016) state that early detection and resuscitation treatment of sepsis can 
reduce mortality from 37% to 30.8%.  Therefore, the eICU will enhance, institute and manage 
the high-quality data surveillance screening tool called CMM to better identify and treat septic 
patients located anywhere in Sutter Solano.  While the use of screening tools plays a valuable 
role in early identification, in the age of EHR, high-quality data surveillance can provide a 
broader range and scope to screening.   
The real-time prospective pilot study of the electronic sepsis surveillance system (ESSV) 
performed by Brandt et al., (2015) ran for 11 days in 2012, involved 477 patients and included a 
30-day retrospective trial.  The ESSV was 100% sensitive for detecting severe sepsis but only 
62.0% specific.  They concluded that though this technology was useful in capturing sepsis, they 
recommended partnering it with surveillance personnel to evaluate the sepsis alerts for false 
positives thereby improving its specificity.  This collaborative partnering could create a valuable 
tool in the identification of patients with severe sepsis who might otherwise go undiagnosed and 
untreated. 
In their article, Harrison, et al., (2015), explain their observational diagnostic 
performance study that involved all patients age >18 years old admitted to ICU over a three-
month period.  They reviewed data to develop and test an electronic sepsis screening tool, which 
they call a sniffer, for capturing delay in recognition and treatment of severe sepsis. They 
incorporated only the criteria of hypoperfusion/systolic blood pressure (SBP) < 90 mm Hg, SIRS 
criteria, suspicion of infection, organ dysfunction, Lactate > 2.0 and shock requiring 
vasopressors in the initial iteration of the sniffer.  Each reiteration included more specific data for 
recognition of end-organ dysfunction and failure: MAP, bilirubin and creatinine levels, Lactate > 
4.0, platelets, INR, mechanical ventilation and PaO2/FiO2 ratios, urinary output and GCS score. 
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Through this study, Harrison, et al., (2015) successfully created what they referred to as a 
severe sepsis ‘sniffer’ which they concluded could accurately identify delay in recognition and 
treatment.  They improved the sniffer’s specificity and sensitivity of 59% and 97% to 80% and 
96% through development of the tool’s algorithm.  Further they found it could also increase 
compliance with early therapeutic and diagnostic interventions.  
Rhee, et al., (2016), performed a comparative retrospective cohort study to determine 
sensitivity and specificity of electronic data surveillance technology to accurately identify sepsis.  
They found that more recent studies gained insights from previous ones and therefore have 
evolved to become more specific and sensitive.  The algorithm development and enhancement 
process undertaken in Harrison’s, et al. (2016) study influences the pattern of implementation, 
enhancement and evolution of the eICU/ICU collaborative project of CMM high-quality sepsis 
data surveillance technology. 
CMM technology was onboarded by the eICU to improve early identification and 
treatment of sepsis and septic shock at Sutter Solano.  Through the eICU personnel’s continuous 
monitoring and evaluation of these alerts, patient’s lives were saved through early detection and 
treatment causing their long-term outcomes to improve.  Through interdepartmental 
collaboration, active use and feedback intervals, the CMM technology will continue to be 
enhanced for appropriate specificity and sensitivity for identification of sepsis.  Once 
accomplished, the enhanced CMM technology can be spread to the other Sutter Health affiliates. 
Timeline 
The timeline began in May 2016 with the distribution of the “Eliminate Harm Initiative” 
report from February to April 2016.  It was this report that revealed the declining sepsis mortality 
outcomes.  On June 21, 2016, the eICU unit champion (and CNL student) initiated a 
IMPROVING SEPSIS MORTALITY                                                                                                         20 
 
collaborative with the Sutter Solano Medical Center’s quality improvement team which 
consisted of their leadership, an educator and an ICU unit champion.  While the two 
collaborative unit champions maintained open communications between the units, Solano’s 
leadership and educator brought the NICOM equipment and technology to their ICU and ED.  
Onboarding this equipment was expedited through the NICOM company’s trial programs and 
educational presentations to staff.  On 7/12, Solano’s quality educator placed me in contact with 
the NICOM company representative so the eICU could also bring educational presentations to its 
critical care management team.  On July 19, 2016, the NICOM representatives came to the eICU 
to provide educational presentations on the use of NICOM to manage septic shock.  By late July, 
Sutter Solano had partnered with the EHR representatives to launch the inclusion of NICOM 
orders in the Sepsis/Septic Shock order sets.  
On August 4, 2016, Sutter Solano’s Medical Champion facilitated physicians and 
physician assistants in collaboration to improve access and application of the orders supporting 
NICOM in EHR.  On August 8, 2016, the eICU Director of Nursing launched the pilot-test 
CMM high-quality data surveillance technology to continuously screen all patients at Sutter 
Solano Medical center for sepsis.  The pilot was initiated for continuous evaluation by the eICU 
RNs to determine its efficacy and sensitivity to capture sepsis cases. During this time frame, 
eICU RNs completed a data base noting any unnecessary data collected by the program.  
Feedback was welcomed and utilized to continually improve the CMM surveillance tool.    
On September 19, 2016, the eICU hosted the eICU Journal Club exploration in the latest 
EBP for fluid responsiveness in sepsis and septic shock.  Those in attendance agreed and  
determined that the PLR in combination with hemodynamic monitoring was the cornerstone for 
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assessing fluid responsiveness in patients with septic shock.  Staff agreed to support this 
initiative throughout its practice. 
On September 26, 2016, the eICU launched its upgraded and feedback-enhanced version 
of the CMM to capture sepsis with increased specificity.  Sutter Solano’s leadership announced 
to their team that the eICU will be will be receiving prompts on the patients that show potential 
for decompensation.  Once the prompt was received, the eICU RN would perform a real-time 
chart review.  All charts requiring intervention would prompt a call for collaborative discussion 
with the bedside RN.  A phone call to a physician or an overhead alert would be implemented if 
needed. 
On September 27, 2016, the collaborating Unit Champions received the ‘go ahead’ for 
the “President’s Award” eICU/ICU collaborative project.  On October 11, 2016, Solano’s 
leadership made a system-wide announcement of vast improvements in the sepsis mortality rates 
attributing it to the improved use of sepsis alerts.  On November 7, 2016, the NICOM 
representative came to the eICU and provided three more consecutive educational presentations 
to most members of the eICU team. 
On December 8, 2016, through continued feedback and another technology upgrade, the 
CMM evolved to screen more rapidly, 600 patients over 15 seconds, and was re-set to run every 
30 minutes. 
On January 13, 2017, Sutter Solano’s ICU Unit Champion worked as a resource to 1:1 
train ICU and ED nurses in the tracking tool’s use in conjunction with NICOM and PLR. Then 
on January 20, 2017, Solano’s ED Unit Champion facilitated the ‘go live’ with its ED to ICU 
NICOM trial scorecard (see “NiCOM Trial Scorecard” Appendix D) screening tool.  This tool 
tracked care providers for each septic patient as well as records of patients’ arrival time, time the 
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sepsis alert was called, door to initial fluid bolus interval, door to NICOM use interval and door 
to re-assessment of fluid status/PLR interval.  It also prompted the care provider to record 
whether the patient was fluid responsive upon re-assessment, whether they were hypotensive or 
required a vasopressor and where the patient was admitted. 
On January 25, 2017, the eICU Unit Champion provided 1:1 education to the eMD to 
properly order NICOM in EHR because the orders were not readily found.  This launched a new 
cycle of improvement.  On January 28, 2017, the various Unit Champions collaborated to 
provide screen-shots of EHR septic shock order sets to provide easier access to eMDs for off-
hour management of these critically ill patients.  Then on February 15, 2017, the eICU Medical 
Director provided all of the eMDs with completed instructions on how to order NICOM in the 
Septic shock order sets. All eMDs then began ordering NICOM and PLR on all patients admitted 
to Sutter Solano Medical Center’s ICU. 
From February through April, the collaborative teams continued incorporating these 
process improvement measures and saw the sepsis and septic shock mortality rate continually 
decrease.  The quality data report in April 2017 revealed the effect of the collaborative efforts 
involved to improved sepsis mortality outcomes at Sutter Solano had dropped the mortality rates 
from 41.2% to 6.1% (See “Poster Presentation” Appendix E). 
Expected Results 
The primary expectation was a decrease in mortality rates for septic patients at Sutter 
Solano Medical Center.  Because of the influential reach and success of this project, other 
leadership in the system are expected to contract to onboard NICOM in effort to improve septic 
shock mortalities at their affiliates. When the CMM alert system is enhanced and evolved to be 
robustly specific and sensitive, it will be proposed to introduce it to all of the affiliates in the 
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system. In conclusion sepsis mortality rates can be reduced through implementing the high-
quality data surveillance technology, CMM, for early identification and treatment of sepsis.  
Further, the use of NICOM in conjunction with PLR for determining fluid responsiveness is the 
most current EBP recommended guideline for fluid resuscitation in sepsis and septic shock. The 
system could conclude to use NICOM and CMM high-quality data surveillance throughout all 
the affiliate hospitals for improved quality outcomes for septic patients. 
Nursing Relevance 
The evaluation of EGDT for fluid resuscitation has been under scrutiny as a Surviving 
Sepsis Campaign guideline since 2012 for its focus on CVP measures to determine fluid 
resuscitation.  Nursing needs to recognize that CVP is no longer recommended or accepted as a 
measure of hemodynamic stability.  The latest EBP supports NICOM in conjunction with PLR as 
a foundational guideline for fluid resuscitation. 
It could be speculated that the next Surviving Sepsis Guidelines will incorporate NICOM 
in conjunction with a PLR to determine fluid responsiveness and guide fluid resuscitation in 
septic patients.  Further the CVP will likely no longer be employed as a 6-hour bundle measure 
along with its accompanying ScVO2 measure.  Rather, the guidelines may be compelled to 
require NICOM/PLR and a focused physical exam that can be performed by nursing with 
physician countersignature to meet 6-hour bundle requirements.  Lastly, the eICU/ICU 
collaborative to improve sepsis mortality is a partnership worth incorporating throughout 
healthcare as a critical care quality improvement measure. 
The value of nursing assessment and evaluation of the septic patient to ensure proper 
standard of care cannot be overstated.  Enhanced high quality data surveillance technology can 
offer benefit to early recognition of sepsis appreciating that most important treatment in sepsis 
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and septic shock is the first antibiotic which must be given within one hour of recognition.  
Further, providing adequate fluid resuscitation and vasopressor rescue and support of the 
cardiovascular system is the next treatment to prioritize.  Care providers must recognize that a 
CVP >8 mmHg is not an indicator of fluid responsiveness and can in fact cause lung and kidney 
injury.  Most importantly, the goal of sepsis treatment is optimal tissue perfusion rather than 
fluid resuscitation.  It is important to remember in the absence of hemodynamic monitoring that 
repeat lactate measures are emphasized as adequate indicators of tissue reperfusion (Hernandez, 
et al., 2012). 
Conclusions 
This project contains many of the qualities of a high-performing clinical microsystem as 
described by the Institute for Healthcare Improvement (2017).  The Institute for Healthcare 
Improvement (IHI) states for a unit to produce synergistic outcomes, it must possess qualities 
such as leadership, being patient-focused and staff attractive, promoting process improvement, 
incorporating macro-system support of its microsystem, optimization of information and 
information technology and being performance driven.  This project contains within its processes 
all of these characteristics. 
First, the project requires microsystem leadership which is supported by Sutter’s eICU 
Director of Nursing and the Sutter Solano leadership.  The project focuses on patients by 
improving outcomes for septic patients and incorporates an interdependent care team.  The 
aspect of the project that brings most of these characteristics together is the implementation of 
the CMM sepsis alert.  It attracts staff from all areas of the hospital to address the patient’s 
needs.  The alert activates lab technicians, radiologists, physicians and intensivists, nurses, 
pharmacists and respiratory therapists to work together seamlessly to provide best practice 
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implementation of interventions in a timely manner.  The CMM sepsis alert depends on 
information provided by nursing documentation and requires information technology to be 
activated within the EHR and communicated to the eICU database.  The project created process 
improvement as all patients who arrive via the ED at Sutter Solano medical Center are now 
electronically screened for sepsis in effort to improve early recognition and treatment.  This 
reflects how the microsystem supports the macro-system changes.  The PDSA cycles already 
implemented correlate to improved outcomes which is an improved performance result. 
The sustainability of this project will be integrated over the course of repeated 
educational presentations regarding NICOM and PLR by representatives and unit champions.  In 
conjunction with local chapter AACN, physician speakers will present this information to many 
accessible locations in the system’s vicinity.  In the eICU, the Journal Club will continue its 
explorations in the latest evidence as it is published.  The CMM technology has continued 
support from staff, leadership and pharmacy administration.  At Sutter Solano, the NICOM/PLR 
technology has been fully adopted and is supported by EHR and a dedicated quality 
improvement team. The project’s initiative interventions are easily adoptable at this stage and are 
already integrated into workflow in both units and throughout the system as presently 
implemented.  Inspired by the improved outcomes at Sutter Solano Medical Center, other Sutter 
ICUs are on-boarding the NICOM technology and considering the CMM technology. 
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Appendix A 
Root Cause Analysis Fishbone Diagram 
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Appendix B 
Cost Benefit Analysis 
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Appendix C 
SWOT Analysis 
 
 
 
 
 
 
 
Strengths: 
 
1. eICU Leadership is very supportive. 
2. ICU leadership is very supportive. 
3. Unit Champions from both sides are 
collaborative. 
4. ICU leadership readily purchases NiCOM 
equipment. 
5. Project contains strong diffusion 
innovation factors. 
Weaknesses: 
 
1. Knowledge level requires exposure and 
education. 
2. Opinion leaders require recruitment. 
3. Strength of initiative requires. 
4. Collaboration between involved units and 
departments required. 
5. CMM monitoring is an additional 
responsibility/duty to eRN workflow 
Opportunities: 
 
1. Sepsis mortality rates could improve from 
41.2% to system benchmark of 18.8%. 
2. Initiative improvements could lead a 
system-wide improvement cycle. 
3. Enhanced CMM technology could benefit 
system. 
4. Instituting NiCOM technologies could 
lead industry towards best EBP. 
Threats: 
 
1. NiCOM use requires standardized 
mechanism PLR to be consistent. 
2. Old information and knowledge currently 
guide care. 
3. Familiar practices of CVP measurements 
are obstacles to incorporating new 
ideologies. 
4. Adequate staffing is required for adequate 
data surveillance. 
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Appendix D 
NiCOM Trial Scorecard 
Date:    
X Emergency Services          ∆ Inpatient Unit 
Patient Initials:  MRN: 
Goals Recorded Time 
 
Total Time Met Goal 
Arrival time    
Sepsis Alert called  
Time? 
   
Door to Fluid Bolus (<45 min goal)  
30ml/Kg 
 
   
Door to NICOM (<60 min goal)    
Door to Reassessment of fluid status 
(< 120 min)  
PLR/FC? 
   
Was Pt Fluid Responsive? 
 
   
Hypotension Present Y/N 
 
   
Vasopressor Started Y/N 
 
   
Transfer location?    
Comments or Concerns?    
ED Provider__________   ED RN_________ Hospitalist___________ ICU RN___________ 
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